EDGAR Filing Documents for 0001012975-17-000446

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001012975-17-000446

Filing Date

2017-05-23

Accepted

2017-05-23 15:19:55

Documents

Effectiveness Date

2017-05-23

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	9332
	Complete submission text file	0001012975-17-000446.txt		10463

Mailing Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202

Business Address 509 S. EXETER ST., SUITE 202 BALTIMORE MD 21202 212-956-1111

Centrexion Therapeutics Corp (Filer) CIK: 0001592052 (see all company filings)